TX HB 7: Relating to prohibitions on the manufacture and provision of abortion-inducing drugs, including the jurisdiction of and effect of certain judgments by courts within and outside this state with respect to the manufacture and provision of those drugs, and to protections from certain counteractions under the laws of other states and jurisdictions; authorizing qui tam actions.
Texas HB 7 expands prohibitions on abortion-inducing drugs, including new qui tam enforcement, which may affect pharmacies handling such drugs. The bill does not directly target controlled substances but could impact dispensing of mifepristone and misoprostol, which are not controlled substances but are regulated under FDA REMS. Pharmacies must ensure compliance with Texas abortion drug laws.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 16, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies in Texas should confirm how it applies to their specific situation before acting. There is a time constraint attached: Effective date of bill (likely 90 days after session end, check specific date). Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
New prohibitions on manufacturing and providing abortion-inducing drugs, with qui tam actions allowing private lawsuits. Pharmacies must verify they are not dispensing these drugs in violation of Texas law.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies in Texas
What you must do
Review current dispensing practices for mifepristone and misoprostol; ensure compliance with Texas abortion drug restrictions; update policies to prevent unauthorized dispensing.
Deadline
Effective date of bill (likely 90 days after session end, check specific date)
Source: https://capitol.texas.gov/BillLookup/History.aspx?LegSess=892&Bill=HB7
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- US-CONGRESS HR7895: PBM Kickback Prohibition Act
- IL HB0004: MEDICAID-PHARMACY SERVICES
- Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661
- Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
- Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Availability